Practical Experience of Implementing the INTERCEPT™ Blood System for Buffy Coat Platelets in a Blood Center

Publisher： Karger

E-ISSN： 1660-3818|31|1|32-36

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.31, Iss.1, 2004-02, pp. : 32-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method

By  

TRANSFUSION, Vol. 55, Iss. 4, 2015-04 ,pp. : 815-823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Buffy Coat Platelets in Platelet Additive Solution with the Mirasol® Pathogen Reduction Technology System

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 1, 2013-01 ,pp. : 44-48

Karger

Access to resources Recommend Favorite

Determining the Volume of Additive Solution and Residual Plasma in Whole Blood Filtered and Buffy Coat Processed Red Cell Concentrates

By  

Transfusion Medicine and Hemotherapy, Vol. 43, Iss. 2, 2015-11 ,pp. : 133-136

Karger

Access to resources Recommend Favorite

Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies

By  

TRANSFUSION, Vol. 55, Iss. 6, 2015-06 ,pp. : 1275-1282

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTM

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 19-31

Karger

Access to resources Recommend Favorite